An interesting involvement of GILZ in GC anti-inflammatory and immunosuppressive effects, which may also impact with cancer, is its ability to inhibit MAPK pathways through binding to some components of the MAPK cascade105. The gene discussed is TSC22D3; the disease is cancer.